| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0078 | 1 |